A. Bouvard

Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics

M. Leboyer, B. Aouizerate, P. Courtet, 2021, Frontiers in Psychiatry.

Cognitive impairments in treatment-resistant depression: results from the French cohort of outpatients (FACE-DR)

M. Leboyer, B. Aouizerate, G. Fond, 2021, Journal of Affective Disorders Reports.

Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markers.

M. Leboyer, B. Aouizerate, P. Courtet, 2023, Journal of affective disorders.

Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity

B. N'Kaoua, D. Misdrahi, M. Dupuy, 2018, Journal de Thérapie Comportementale et Cognitive.

Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study

M. Leboyer, B. Aouizerate, P. Courtet, 2023, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls

D. Misdrahi, M. Dupuy, F. Serre, 2018, The American journal on addictions.

Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.

E. Haffen, D. Bennabi, W. El-Hage, 2023, Journal of affective disorders.

Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort

M. Leboyer, B. Aouizerate, P. Courtet, 2023, Brain sciences.